Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.43 |
| ▸ | NNMT | P40261 | 1/20 | 0.42 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18097901 | 0.87 | MEN1 (0.41) | ACACBNNMTKLKB1MAPTMEN1 | |
| SCHEMBL7081683 | 0.86 | ACACB (0.49) | ACACBNNMTKLKB1MKNK1MKNK2 | |
| SCHEMBL3604889 | 0.86 | ACACB (0.49) | ACACBNNMTKLKB1MKNK1MKNK2 | |
| SCHEMBL27805611 | 0.85 | SLC7A5 (0.40) | SLC7A5MAPTKMT2ALMNAPOLB | |
| SCHEMBL4072789 | 0.85 | SLC7A5 (0.40) | SLC7A5MAPTKMT2ALMNAPOLB | |
| SCHEMBL7945973 | 0.84 | ACACB (0.44) | ACACBNNMTKLKB1MKNK1MKNK2 | |
| SCHEMBL3861143 | 0.84 | ACACB (0.44) | ACACBNNMTKLKB1MKNK1MKNK2 | |
| SCHEMBL4601596 | 0.82 | HSD17B10 (0.53) | ACACBNNMTKLKB1SLC7A5MEN1 | |
| SCHEMBL4601600 | 0.82 | HSD17B10 (0.53) | ACACBNNMTKLKB1SLC7A5MEN1 | |
| SCHEMBL7518497 | 0.79 | LDHA (0.53) | ACACBSLC7A5SMN1; SMN2POLBLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1230240-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |
| EP-1230240-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 2002-08-14 | — | — | EP | claimed |
| WO-2001034602-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-17 | — | — | WO | claimed |
| EP-1230240-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1230240-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| US-6407241-B1 | REACTING THE CORRESPONDING WITH AMINE AND PHOSGENE; CYCLIZATION; THERAPY FOR BONE DISORDERS; ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. | 2002-06-18 | — | — | US | disclosed |
| WO-2001034602-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-17 | — | — | WO | disclosed |